Antihistamine pretreatment to reduce incidence of withdrawal movement after rocuronium injection

J Korean Med Sci. 2009 Oct;24(5):879-82. doi: 10.3346/jkms.2009.24.5.879. Epub 2009 Sep 24.

Abstract

The purpose of this study was to determine the effectiveness of antihistamine therapy for withdrawal movements caused by rocuronium injection. One hundred seventy one ASA I-II adults undergoing elective surgery were randomly assigned to one of two groups. Patients in the control group (Group C) were premedicated with 2 mL normal saline, and those in the antihistamine group (Group A) were pre-medicated with 2 mL (45.5 mg) pheniramine maleate. After the administration of thiopental sodium 5 mg/kg, rocuronium 0.6 mg/kg was injected. Withdrawal movements were assessed using a four-grade scale. The administration of antihistamine reveals lower grade of withdrawal movement after rocuronium injection.

Keywords: Antihistamine; Pain; Rocuronium.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Androstanols / administration & dosage*
  • Androstanols / adverse effects
  • Anesthetics, Intravenous / administration & dosage
  • Double-Blind Method
  • Female
  • Histamine H1 Antagonists / pharmacology*
  • Humans
  • Incidence
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Movement / drug effects
  • Movement / physiology
  • Neuromuscular Nondepolarizing Agents / administration & dosage*
  • Neuromuscular Nondepolarizing Agents / adverse effects
  • Pain / chemically induced
  • Pain Measurement
  • Pheniramine / pharmacology*
  • Rocuronium
  • Thiopental / administration & dosage

Substances

  • Androstanols
  • Anesthetics, Intravenous
  • Histamine H1 Antagonists
  • Neuromuscular Nondepolarizing Agents
  • Pheniramine
  • Thiopental
  • Rocuronium